Calithera Biosciences, Inc.
CALA
Revenue
6.75M
▲3.75M▲125.00%
3 Months ChangeAssets
28.68M
▼-8.41M▼-22.67%
3 Months ChangeLiabilities
8.28M
▼-2.41M▼-22.54%
3 Months ChangeFree Cash Flow
-27.03M
▼-12.05M▼-80.45%
24 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2023-01-25
Form 8-K
ID: 0001193125-23-014684
2023-01-09
Form 8-K
ID: 0001193125-23-004182
2022-11-14
Form 10-Q
ID: 0000950170-22-025060
2022-11-14
Form 8-K
ID: 0001193125-22-284548
2022-09-29
Form 8-K
ID: 0001193125-22-254302
2022-08-16
Form 10-Q
ID: 0000950170-22-017478
2022-08-15
Form 8-K
ID: 0001193125-22-221273
2022-06-14
Form 8-K
ID: 0001193125-22-173862
2022-06-03
Form 8-K
ID: 0001193125-22-167374
2022-05-23
Form 8-K
ID: 0001193125-22-157530